Back to Search Start Over

Flavaglines as natural products targeting eIF4A and prohibitins: From traditional Chinese medicine to antiviral activity against coronaviruses

Authors :
Stéphan Vagner
Duncan R. Smith
Christiane Moog
Nadia Benkirane-Jessel
Laurent Désaubry
Canan G. Nebigil
Nanomédecine Régénérative (NanoRegMed)
Université de Strasbourg (UNISTRA)-Institut National de la Santé et de la Recherche Médicale (INSERM)
Désaubry, Laurent
Immuno-Rhumatologie Moléculaire
Intégrité du génome, ARN et cancer
Institut Curie [Paris]-Université Paris-Saclay-Centre National de la Recherche Scientifique (CNRS)
Source :
European Journal of Medicinal Chemistry, European Journal of Medicinal Chemistry, Elsevier, 2020, 203, pp.112653. ⟨10.1016/j.ejmech.2020.112653⟩, European Journal of Medicinal Chemistry, 2020, 203, pp.112653. ⟨10.1016/j.ejmech.2020.112653⟩
Publication Year :
2020

Abstract

Flavaglines are cyclopenta[b]benzofurans found in plants of the genus Aglaia, several species of which are used in traditional Chinese medicine. These compounds target the initiation factor of translation eIF4A and the scaffold proteins prohibitins-1 and 2 (PHB1/2) to exert various pharmacological activities, including antiviral effects against several types of viruses, including coronaviruses. This review is focused on the antiviral effects of flavaglines and their therapeutic potential against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2).<br />Graphical abstract Image 1<br />Highlights • Flavaglines are complex natural products found in plants used in traditional Chinese medicine. • Flavaglines target the initiation factor of translation eIF4A and the scaffold proteins prohibitins-1 and 2 (PHB1/2). • Flavaglines display potent antiviral activities against several viruses including SARS-CoV-2 responsible of COVID-19.

Details

Language :
English
ISSN :
02235234 and 17683254
Database :
OpenAIRE
Journal :
European Journal of Medicinal Chemistry, European Journal of Medicinal Chemistry, Elsevier, 2020, 203, pp.112653. ⟨10.1016/j.ejmech.2020.112653⟩, European Journal of Medicinal Chemistry, 2020, 203, pp.112653. ⟨10.1016/j.ejmech.2020.112653⟩
Accession number :
edsair.doi.dedup.....9dc5b83866a52cb14cf7a829649be23e